Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Accounts receivable (Details)

v3.8.0.1
Summary of Significant Accounting Policies - Accounts receivable (Details)
$ in Thousands
Dec. 31, 2017
USD ($)
customer
Dec. 31, 2016
USD ($)
customer
Accounts receivable    
Allowance for doubtful accounts | $ $ 0 $ 0
GlaxoSmithKline Intellectual Property Development Ltd    
Accounts receivable    
Number of customers | customer 1 1